Peer-reviewed veterinary case report
Antiparkinsonian Activity of Benzenesulfonamide Derivatives, Selective MAO-B Inhibitors.
- Journal:
- Bulletin of experimental biology and medicine
- Year:
- 2025
- Authors:
- Khokhlov, A L et al.
- Affiliation:
- Yaroslavl State Medical University
- Species:
- rodent
Abstract
The anti-parkinsonian activity of benzolsulfonamide selective MAO-B inhibitors was evaluated in a model of experimental parkinsonism in white mice (systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPTP). Six candidate compounds (laboratory codes S6-S8 and S11-S13) were analyzed. Rasagiline was used as the reference drug. Only compound S13 was comparable to rasagiline in preventing the development of rigidity and hypokinesia in animals and surpassed the reference drug in correcting emotional and behavioral activity.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/40996645/